Oral News and Research

RSS

Scientists crack tooth decay

About half of today’s children have tooth decay, so a new solution that blocks the action of bacteria which attack teeth could bring significant benefits, according to scientists speaking Monday at the Society for General Microbiology’s 155th Meeting at Trinity College Dublin.

7 Sep 2004

People should be aware of the risks of herbal remedies interacting with conventional medicines

A high percentage of the population could be endangering their health by taking herbal medicines without checking with a health professional first according to Peter Houghton, Professor in Pharmacognosy, King’s College London.

7 Sep 2004

New drug application for exenatide has been accepted for review

Amylin Pharmaceuticals and Eli Lilly today announced that the New Drug Application for exenatide has been accepted for review by the Food and Drug Administration.

2 Sep 2004

New sedation procedure which could allow patients to avoid potentially risky general anaesthetics

Dental experts have developed a new sedation procedure which could relieve pressure on hospitals and allow patients to avoid potentially risky general anaesthetics.

1 Sep 2004

MGI PHARMA acquires Aesgen for $32 million

MGI PHARMA today announced that they have signed a definitive merger agreement under which MGI PHARMA will acquire all outstanding equity of Aesgen for $32 million in cash.

1 Sep 2004

Summary of The Euro Heart Survey on the diabetic state of patients with coronary artery disease

The survey engaged 110 centres in 25 countries recruiting 4,196 patients referred to a cardiology department or outpatient clinic due to CAD. A total of 2 107 of these patients were admitted on acute basis while 2,854 had an elective consultation. Patient data were collected via a web-based case record form.

30 Aug 2004

New study confirms benefits of rimonabant in weight loss

Phase III clinical study comparing placebo to rimonabant, the first agent in a new therapeutic class known as selective cannabinoid type 1 (CB1) blockers, showed that overweight or obese people taking rimonabant 20mg once daily benefited from a significant reduction in their body weight

29 Aug 2004

Solid evidence that best treatment for multiple sclerosis is pregnancy

For years, doctors have suggested the best treatment for multiple sclerosis is pregnancy. Now, an Oregon study is delivering solid evidence to support the theory.

27 Aug 2004

High tech implants to aid facial reconstruction

Loughborough University researchers have been awarded more than £200,000 to develop state-of-the-art tailor made implants for people requiring facial reconstructive surgery.

27 Aug 2004

Surgeons remodel and replace man's jaw bone allowing him to eat first dinner in 9 years

“By the 4th week post-transplantation the patient enjoyed his first dinner in 9 years (bread and sausages); before reconstruction he had only been able to eat soft food and soup”.

26 Aug 2004

Probiotics of no use for vaginal problems

"Friendly" bacteria (probiotics) are widely used and recommended for general health and specifically for vaginal problems.

26 Aug 2004

Popular injectable contraceptive increases risk of STD's

The injectable contraceptive depot-medroxyprogesterone acetate (DMPA) appears to increase a woman’s risk of acquiring the sexually transmitted infections chlamydia and gonorrhea by approximately three fold when compared to women not using a hormonal contraceptive

23 Aug 2004

Diarrhea the leading cause of death among the developing world's children

To most people in the developed world, diarrhea is a nuisance. It means some discomfort and maybe a trip to the local pharmacy.

23 Aug 2004

Clearing toxins in the brains of Alzheimer's patients can stave off future reductions in cognitive abilities

The ever-slowing capacity to clear the build-up of such toxins as isoprostanes and misfolded proteins that accumulate in the brains of Alzheimer's disease patients causes the death of cells involved in memory and language.

23 Aug 2004

Gene variant that is a major contributor to cleft lip

An international team of researchers has identified a gene variant that is a major contributor to oral clefts and triples the risk of recurrence in affected families, it was reported today in The New England Journal of Medicine.

18 Aug 2004

Two more drugs added to Medicare demonstration program

The Centers for Medicare & Medicaid Services has announced it is adding two more drugs to the list of drugs covered under a Medicare demonstration program providing substantial savings to beneficiaries with serious diseases, including cancer, multiple sclerosis, and rheumatoid arthritis.

17 Aug 2004

2004 AIDS Vaccine Conference has announced it's forthcoming programme

The Conference will examine the entire spectrum of issues in AIDS vaccine development and deployment, including the global effort in preventative and therapeutic vaccines, immunology, pediatric and adolescent vaccines, clinical trials in emerging countries and the need for strong political and financial commitment.

17 Aug 2004

Drug developers should take a different approach to snake venom and heart medications

With the help of snake venom and sophisticated laboratory testing, scientists believe they've uncovered the reason why a group of new heart medications were doing some patients more harm than good.

17 Aug 2004

Benefits from short-term hormone therapy are likely to outweigh the risks

A group of prominent experts on treatment of the menopause today issued advice for doctors on the use of hormone therapy.

13 Aug 2004

The U.S. FDA approves 2 drugs for treating radiation contamination

The U.S. Food and Drug Administration has approved two drugs, pentetate calcium trisodium injection (Ca-DTPA) and pentetate zinc trisodium injection (Zn-DTPA) for treating certain kinds of radiation contamination. The FDA is approving these two drugs as part of its ongoing effort to provide the American public the best available protection against nuclear accidents and terrorist threats.

11 Aug 2004